Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

8.50USD
22 Jan 2018
Change (% chg)

$0.41 (+5.07%)
Prev Close
$8.09
Open
$8.48
Day's High
$9.10
Day's Low
$8.21
Volume
223,845
Avg. Vol
82,553
52-wk High
$9.22
52-wk Low
$3.88

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.21 December 23 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 3 3 3
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 5 11.43 22.00 4.00 11.47
Quarter Ending Jun-18 5 11.53 22.00 4.00 11.47
Year Ending Dec-18 7 52.40 88.00 32.50 37.69
Earnings (per share)
Quarter Ending Mar-18 5 -0.21 -0.10 -0.25 -0.23
Quarter Ending Jun-18 5 -0.21 -0.09 -0.27 -0.25
Year Ending Dec-18 6 -0.81 -0.39 -1.29 -1.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 6.26 27.18 20.93 334.54
Quarter Ending Jun-17 5.40 3.52 1.88 34.80
Quarter Ending Mar-17 4.92 2.86 2.07 41.97
Quarter Ending Dec-16 3.83 8.54 4.70 122.68
Quarter Ending Sep-16 5.32 2.42 2.90 54.59
Earnings (per share)
Quarter Ending Sep-17 -0.23 -0.01 0.22 -96.03
Quarter Ending Jun-17 -0.25 -0.24 0.01 -2.72
Quarter Ending Mar-17 -0.26 -0.30 0.04 -13.64
Quarter Ending Dec-16 -0.27 -0.24 0.03 -11.76
Quarter Ending Sep-16 -0.28 -0.24 0.04 -14.29

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 11.43 11.43 11.43 11.43 11.47
Quarter Ending Jun-18 11.53 11.53 11.53 11.53 11.47
Year Ending Dec-18 52.40 52.40 52.40 52.40 37.69
Earnings (per share)
Quarter Ending Mar-18 -0.21 -0.21 -0.21 -0.21 -0.23
Quarter Ending Jun-18 -0.21 -0.21 -0.21 -0.21 -0.25
Year Ending Dec-18 -0.81 -0.81 -0.81 -0.81 -1.12

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0